"Even if I didn't lose another pound, I'd take this drug as long as I could," Halstead said. "But at $700 a month, that's not ...

周一，BMO Capital Markets 强调了礼来公司假期前产品销售的积极前景。分析师观察到，礼来公司的糖尿病和肥胖症治疗药物 Mounjaro 和 Zepbound 的总处方量和新处方量明显上升，总处方量（TRx）分别增长了 4.5% 和 5.7%。

钛媒体App ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

【11 月 27 日，安进公司公布减肥药 MariTide 试验结果】在为期一年的试验中，非糖尿病患者每月或更少频次服用一次 MariTide，最多减轻 20%体重。 分析人士指出，其效果与礼来的 Zepbound 最高剂量相当，但 Zepbound ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...

Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...